BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29912913)

  • 21. Randomized, double-blind, placebo-controlled study of oral lactobacilli to improve the vaginal flora of postmenopausal women.
    Petricevic L; Unger FM; Viernstein H; Kiss H
    Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):54-7. PubMed ID: 18701205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of probiotics on genital high-risk human papilloma virus clearance and quality of cervical smear: a randomized placebo-controlled trial.
    Ou YC; Fu HC; Tseng CW; Wu CH; Tsai CC; Lin H
    BMC Womens Health; 2019 Jul; 19(1):103. PubMed ID: 31340789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial.
    Anukam K; Osazuwa E; Ahonkhai I; Ngwu M; Osemene G; Bruce AW; Reid G
    Microbes Infect; 2006 May; 8(6):1450-4. PubMed ID: 16697231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lactobacillus probiotics restore vaginal and gut microbiota of pregnant women with vaginal candidiasis.
    Ang XY; Roslan NS; Ahmad N; Yusof SM; Abdullah N; Nik Ab Rahman NN; Woon JJ; Teh CS; Todorov SD; Liu G; Liong MT
    Benef Microbes; 2023 Nov; 14(5):421-431. PubMed ID: 38350486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Administration of two probiotic strains during early childhood does not affect the endogenous gut microbiota composition despite probiotic proliferation.
    Laursen MF; Laursen RP; Larnkjær A; Michaelsen KF; Bahl MI; Licht TR
    BMC Microbiol; 2017 Aug; 17(1):175. PubMed ID: 28818050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaginal probiotic adherence and acceptability in Rwandan women with high sexual risk participating in a pilot randomised controlled trial: a mixed-methods approach.
    Verwijs MC; Agaba S; Umulisa MM; Uwineza M; Nivoliez A; Lievens E; van de Wijgert JHHM
    BMJ Open; 2020 May; 10(5):e031819. PubMed ID: 32434932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women.
    Reid G; Charbonneau D; Erb J; Kochanowski B; Beuerman D; Poehner R; Bruce AW
    FEMS Immunol Med Microbiol; 2003 Mar; 35(2):131-4. PubMed ID: 12628548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora.
    Reid G; Beuerman D; Heinemann C; Bruce AW
    FEMS Immunol Med Microbiol; 2001 Dec; 32(1):37-41. PubMed ID: 11750220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study.
    Vicariotto F; Del Piano M; Mogna L; Mogna G
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S73-80. PubMed ID: 22955364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of Lactobacillus acidophilus and rhamnosus in the reduction of bacterial load of Helicobacter pylori and modification of gut microbiota-a double-blind, placebo-controlled, randomized trial.
    Chen MJ; Chen CC; Huang YC; Tseng CC; Hsu JT; Lin YF; Fang YJ; Wu MS; Liou JM;
    Helicobacter; 2021 Dec; 26(6):e12857. PubMed ID: 34708471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probiotic Lactobacilli for urogenital health in women.
    Reid G
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S234-6. PubMed ID: 18685506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of probiotics on the cervical malignancy diagnostics quality.
    Perisić Z; Perisić N; Golocorbin Kon S; Vesović D; Jovanović AM; Mikov M
    Vojnosanit Pregl; 2011 Nov; 68(11):956-60. PubMed ID: 22191313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term Lactobacillus rhamnosus BMX 54 application to restore a balanced vaginal ecosystem: a promising solution against HPV-infection.
    Palma E; Recine N; Domenici L; Giorgini M; Pierangeli A; Panici PB
    BMC Infect Dis; 2018 Jan; 18(1):13. PubMed ID: 29304768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of probiotics (Vivomixx®) in obese pregnant women and their newborn: study protocol for a randomized controlled trial.
    Halkjaer SI; Nilas L; Carlsen EM; Cortes D; Halldórsson TI; Olsen SF; Pedersen AE; Krogfelt KA; Petersen AM
    Trials; 2016 Oct; 17(1):491. PubMed ID: 27724923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breastfeeding-associated microbiota in human milk following supplementation with Lactobacillus rhamnosus GG, Lactobacillus acidophilus La-5, and Bifidobacterium animalis ssp. lactis Bb-12.
    Simpson MR; Avershina E; Storrø O; Johnsen R; Rudi K; Øien T
    J Dairy Sci; 2018 Feb; 101(2):889-899. PubMed ID: 29248229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Probiotic monotherapy of bacterial vaginosis: a open, randomized trial].
    Kovachev S; Dobrevski-Vacheva R
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():36-42. PubMed ID: 24294744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Lactobacillus rhamnosus HN001 in Pregnancy on Postpartum Symptoms of Depression and Anxiety: A Randomised Double-blind Placebo-controlled Trial.
    Slykerman RF; Hood F; Wickens K; Thompson JMD; Barthow C; Murphy R; Kang J; Rowden J; Stone P; Crane J; Stanley T; Abels P; Purdie G; Maude R; Mitchell EA;
    EBioMedicine; 2017 Oct; 24():159-165. PubMed ID: 28943228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14.
    Martinez RC; Franceschini SA; Patta MC; Quintana SM; Candido RC; Ferreira JC; De Martinis EC; Reid G
    Lett Appl Microbiol; 2009 Mar; 48(3):269-74. PubMed ID: 19187507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential vaginal probiotics: safety, tolerability and preliminary effectiveness.
    Rostok M; Hütt P; Rööp T; Smidt I; Štšepetova J; Salumets A; Mändar R
    Benef Microbes; 2019 Apr; 10(4):385-393. PubMed ID: 30882242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testing the regulatory framework in South Africa - a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis.
    Happel AU; Singh R; Mitchev N; Mlisana K; Jaspan HB; Barnabas SL; Passmore JS
    BMC Infect Dis; 2020 Jul; 20(1):491. PubMed ID: 32650729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.